Announced Sat, 6 Jun, 2026 · 16:05 IST
Alembic Pharma to invest 45 percent in new Canadian pharma JV
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹742.75
prior close
₹742.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.4+0.4-0.2-1.4-0.9-1.0+0.3-0.5+0.0+10.6+10.2+12.3+9.1
Up moveDown movePending
AI summary
Alembic Pharmaceuticals has signed a Shareholders Agreement to take a 45 percent stake in a newly incorporated Canadian Corporation, 17989377 Canada Inc. Difgen Holdings LLC will hold 45 percent and Mr Sukhad Juneja 10 percent. The JV will develop, commercialise, distribute and market pharmaceutical products in Canada. The Canadian entity will become an associate of Alembic. The deal is not a related party transaction.
Likely market impact
Strategic move into the Canadian pharma market; minority stake limits capital risk while opening a new international growth avenue.